View More Recent Stories
-
TD Cowen Reiterates Buy Rating on Abbott Labs (ABT), PT $130
-
Stifel Reiterates Buy Rating on Abbott Labs (ABT)
-
Citi Reiterates Buy Rating on Abbott Labs (ABT)
-
Abbott (ABT) Tops Q2 EPS by 3c, Updates Guidance
-
Abbott (ABT) call put ratio 4.9 calls to 1 put into quarter results
-
Abbott (ABT) July 103 straddle into quarter results
-
TD Cowen Reiterates Buy Rating on Abbott Labs (ABT)
-
TD Cowen Reiterates Buy Rating on Abbott Labs (ABT)
-
Abbott (ABT) Declares $0.55 Quarterly Dividend; 2.1% Yield
-
Abbott (ABT) Receives FDA Clearance for Two New OTC Continuous Glucose Monitoring Systems
-
Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems
-
Abbott (ABT) Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems
